Otsuka America Pharmaceutical Inc.
Rockville, MD
- UEI
- QKABLBMA8FT9
- CAGE
- 0ZHV7
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 2440 Research Blvd, Rockville, MD 20850, USA
- Website
- otsuka-us.com
- Founded
- 1921
- Employees
- 10K-50K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Jynarque 45MG, 15 MG | Veterans Integrated Service Network 5 | $20,378 | |
| Jynarque 90MG-30MG | Veterans Integrated Service Network 5 | $13,168 | |
| Jynarque 45MG-15MG | Veterans Integrated Service Network 5 | $13,243 | |
| Jynarque 90MG-30MG | Veterans Integrated Service Network 5 | $13,168 | |
| Jynarque 90MG-30MG | Veterans Integrated Service Network 5 | $13,168 |
About Otsuka America Pharmaceutical Inc.
Otsuka America Pharmaceutical Inc. is a for-profit pharmaceutical manufacturer headquartered in Rockville, Maryland, specializing in the development and distribution of pharmaceutical products, particularly medications for treating complex medical conditions. As a federal contractor, the company primarily supplies specialty pharmaceuticals to the Department of Veterans Affairs (VA), with its most prominent product being Jynarque (tolvaptan), a medication used to treat autosomal dominant polycystic kidney disease and hyponatremia. The company is registered in the System for Award Management (SAM) and operates as a corporate entity that manufactures pharmaceutical goods for government healthcare systems.
Through its federal contract awards, Otsuka America Pharmaceutical Inc. has consistently provided specialized pharmaceutical products to the VA's Veterans Health Administration, with a focus on delivering medications through the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract awards are predominantly delivery orders for Jynarque in various dosages, ranging from $10,000 to $113,000, and are issued to multiple VA Integrated Service Networks, including VISN 5, VISN 6, VISN 20, VISN 21, and VISN 22. These contracts are uniformly awarded on a firm-fixed price basis and do not utilize any set-aside designations, reflecting the company's status as a large pharmaceutical manufacturer. The delivery orders support the VA's mission of providing specialized pharmaceutical treatments to veterans across the United States.
Otsuka America Pharmaceutical Inc. holds significant Indefinite Delivery Vehicles (IDVs) with the VA, most notably a $83,342,090.00 Blanket Purchase Agreement (BPA) for Jynarque awarded by the National Acquisition Center, with an ultimate completion date of March 26, 2026. This BPA is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and enables VA facilities across multiple Integrated Service Networks to efficiently procure Jynarque. Additionally, the company maintains a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products, which further demonstrates its established capability to supply federal healthcare systems. These IDVs facilitate task orders that support the VA's comprehensive healthcare services, allowing for streamlined procurement of critical pharmaceutical treatments for veterans nationwide.
Contract vehicles
Quick answers
What is Otsuka America Pharmaceutical Inc.'s UEI?
Otsuka America Pharmaceutical Inc.'s Unique Entity ID (UEI) in SAM.gov is QKABLBMA8FT9.
What is Otsuka America Pharmaceutical Inc.'s CAGE code?
Otsuka America Pharmaceutical Inc.'s CAGE code is 0ZHV7.
What is Otsuka America Pharmaceutical Inc.'s primary NAICS code?
Otsuka America Pharmaceutical Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Otsuka America Pharmaceutical Inc. located?
Otsuka America Pharmaceutical Inc.'s physical address in SAM.gov is 2440 Research Blvd, Rockville, MD 20850, USA.
Is Otsuka America Pharmaceutical Inc. registered in SAM.gov?
Yes. Otsuka America Pharmaceutical Inc.'s SAM.gov registration is active through September 21, 2027.
Which contract vehicles does Otsuka America Pharmaceutical Inc. hold?
Otsuka America Pharmaceutical Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Otsuka America Pharmaceutical Inc.'s most recent federal award?
Otsuka America Pharmaceutical Inc.'s most recent federal contract award is Jynarque 45MG, 15 MG (36C24526N0783), from Veterans Integrated Service Network 5, on July 30, 2026.
On GovTribe
See Otsuka America Pharmaceutical Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors